{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:22:19Z","timestamp":1793733739342,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although alterations in chromatin structure are known to exist in tumors, how these alterations relate to molecular phenotypes in cancer remains to be demonstrated. Multi-omics profiling of human tumors can provide insight into how alterations in chromatin structure are propagated through the pathway of gene expression to result in malignant protein expression. We applied multi-omics profiling of chromatin accessibility, RNA abundance, and protein abundance to 36 human thyroid cancer primary tumors, metastases, and patient-match normal tissue. Through quantification of chromatin accessibility associated with active transcription units and global protein expression, we identify a local chromatin structure that is highly correlated with coordinated RNA and protein expression. In particular, we identify enhancers located within gene-bodies as predictive of correlated RNA and protein expression, that is independent of overall transcriptional activity. To demonstrate the generalizability of these findings we also identify similar results in an independent cohort of human breast cancers. Taken together, these analyses suggest that local enhancers, rather than distal enhancers, are likely most predictive of cancer gene expression phenotypes. This allows for identification of potential targets for cancer therapeutic approaches and reinforces the utility of multi-omics profiling as a methodology to understand human disease.<\/jats:p>","DOI":"10.1038\/s41467-021-25872-1","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T10:19:49Z","timestamp":1632997189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Chromatin accessibility associates with protein-RNA correlation in human cancer"],"prefix":"10.1038","volume":"12","author":[{"given":"Akshay","family":"Sanghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0155-7412","authenticated-orcid":false,"given":"Ahmed","family":"Metwally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8393-4196","authenticated-orcid":false,"given":"John","family":"Sunwoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Orloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9459-4393","authenticated-orcid":false,"given":"Howard Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Kasowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0784-7987","authenticated-orcid":false,"given":"Michael P.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"25872_CR1","doi-asserted-by":"crossref","unstructured":"ENCODE Project Consortium et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799\u2013816 (2007).","DOI":"10.1038\/nature05874"},{"key":"25872_CR2","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1101\/gr.193342.115","volume":"25","author":"C Cenik","year":"2015","unstructured":"Cenik, C. et al. Integrative analysis of RNA, translation, and protein levels reveals distinct regulatory variation across humans. Genome Res. 25, 1610\u20131621 (2015).","journal-title":"Genome Res."},{"key":"25872_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41586-020-2151-x","volume":"583","author":"F Grubert","year":"2020","unstructured":"Grubert, F. et al. Landscape of cohesin-mediated chromatin loops in the human genome. Nature 583, 737\u2013743 (2020).","journal-title":"Nature"},{"key":"25872_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature13985","volume":"515","author":"Y Cheng","year":"2014","unstructured":"Cheng, Y. et al. Principles of regulatory information conservation between mouse and human. Nature 515, 371\u2013375 (2014).","journal-title":"Nature"},{"key":"25872_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu, Y., Beyer, A. & Aebersold, R. On the dependency of cellular protein levels on mRNA abundance. Cell 165, 535\u2013550 (2016).","journal-title":"Cell"},{"key":"25872_CR6","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cell.2019.10.007","volume":"179","author":"DJ Clark","year":"2019","unstructured":"Clark, D. J. et al. Clinical proteomic tumor analysis consortium. integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell 179, 964\u2013983 (2019).","journal-title":"Cell"},{"key":"25872_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature13438","volume":"513","author":"B Zhang","year":"2014","unstructured":"Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382\u2013387 (2014).","journal-title":"Nature"},{"key":"25872_CR8","unstructured":"Corces, M. R. et al. The chromatin accessibility landscape of primary human cancers. Science 362, eaav1898 (2018)."},{"key":"25872_CR9","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.3646","volume":"48","author":"MR Corces","year":"2016","unstructured":"Corces, M. R. et al. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat. Genet. 48, 1193\u20131203 (2016).","journal-title":"Nat. Genet."},{"key":"25872_CR10","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869\u201310874 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25872_CR11","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMra1501993","volume":"375","author":"JA Fagin","year":"2016","unstructured":"Fagin, J. A. & Wells, S. A. Jr. Biologic and clinical perspectives on thyroid cancer. N. Engl. J. Med. 375, 1054\u20131067 (2016).","journal-title":"N. Engl. J. Med."},{"key":"25872_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research Network.","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676\u2013690 (2014).","journal-title":"Cell"},{"key":"25872_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas Network.","year":"2012","unstructured":"Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","journal-title":"Nature"},{"key":"25872_CR14","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3390\/biom10121606","volume":"10","author":"SM Lancaster","year":"2020","unstructured":"Lancaster, S. M., Sanghi, A., Wu, S. & Snyder, M. P. A customizable analysis flow in integrative multi-omics. Biomolecules 10, 1606 (2020).","journal-title":"Biomolecules"},{"key":"25872_CR15","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D. et al. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213\u20131218 (2013).","journal-title":"Nat. Methods"},{"key":"25872_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2015.63","volume":"2","author":"JY Choy","year":"2015","unstructured":"Choy, J. Y. et al. A resource of ribosomal RNA-depleted RNA-Seq data from different normal adult and fetal human tissues. Sci. Data 2, 150063 (2015).","journal-title":"Sci. Data"},{"key":"25872_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cels.2017.12.013","volume":"6","author":"BD Piening","year":"2018","unstructured":"Piening, B. D. et al. Integrative personal omics profiles during periods of weight gain and loss. Cell Syst. 6, 157\u2013170 (2018).","journal-title":"Cell Syst."},{"key":"25872_CR18","doi-asserted-by":"crossref","unstructured":"Kasowski, M. et al. Extensive variation in chromatin states across humans. Science 342, 750\u2013752 (2013).","DOI":"10.1126\/science.1242510"},{"key":"25872_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cell.2018.11.029","volume":"10","author":"M Gasperini","year":"2019","unstructured":"Gasperini, M. et al. A Genome-wide framework for mapping gene regulation via cellular genetic screens. Cell 10, 377\u2013390 (2019).","journal-title":"Cell"},{"key":"25872_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1101\/gr.152140.112","volume":"23","author":"NC Sheffield","year":"2013","unstructured":"Sheffield, N. C. et al. Patterns of regulatory activity across diverse human cell types predict tissue identity, transcription factor binding, and long-range interactions. Genome Res. 23, 777\u2013788 (2013).","journal-title":"Genome Res."},{"key":"25872_CR21","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.cell.2013.11.033","volume":"155","author":"AS Nord","year":"2013","unstructured":"Nord, A. S. et al. Rapid and pervasive changes in genome-wide enhancer usage during mammalian development. Cell 155, 1521\u20131531 (2013).","journal-title":"Cell"},{"key":"25872_CR22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.cell.2015.07.048","volume":"162","author":"F Grubert","year":"2015","unstructured":"Grubert, F. et al. Genetic control of chromatin states in humans involves local and distal chromosomal interactions. Cell 162, 1051\u20131065 (2015).","journal-title":"Cell"},{"key":"25872_CR23","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","volume":"159","author":"SS Rao","year":"2014","unstructured":"Rao, S. S. et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665\u20131680 (2014).","journal-title":"Cell"},{"key":"25872_CR24","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1523\/JNEUROSCI.5893-10.2011","volume":"31","author":"EA Jones","year":"2011","unstructured":"Jones, E. A. et al. Regulation of the PMP22 gene through an intronic enhancer. J. Neurosci. 31, 4242\u20134250 (2011).","journal-title":"J. Neurosci."},{"key":"25872_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1210\/me.2009-0140","volume":"24","author":"LA Zella","year":"2010","unstructured":"Zella, L. A. et al. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol. Endocrinol. 24, 128\u2013147 (2010).","journal-title":"Mol. Endocrinol."},{"key":"25872_CR26","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1182\/bloodadvances.2019000378","volume":"13","author":"EH Bresnick","year":"2019","unstructured":"Bresnick, E. H. & Johnson, K. D. Blood disease-causing and -suppressing transcriptional enhancers: general principles and GATA2 mechanisms. Blood Adv. 13, 2045\u20132056 (2019).","journal-title":"Blood Adv."},{"key":"25872_CR27","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.stemcr.2019.04.004","volume":"12","author":"SL Battle","year":"2019","unstructured":"Battle, S. L. et al. Enhancer chromatin and 3D genome architecture changes from naive to primed human embryonic stem cell states. Stem Cell Rep. 12, 1129\u20131144 (2019).","journal-title":"Stem Cell Rep."},{"key":"25872_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41576-018-0089-8","volume":"20","author":"SL Klemm","year":"2019","unstructured":"Klemm, S. L., Shipony, Z. & Greenleaf, W. J. Chromatin accessibility and the regulatory epigenome. Nat. Rev. Genet. 20, 207\u2013220 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"25872_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nature11212","volume":"489","author":"S Neph","year":"2012","unstructured":"Neph, S. et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 489, 83\u201390 (2012).","journal-title":"Nature"},{"key":"25872_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18035-1","volume":"11","author":"M Bentsen","year":"2020","unstructured":"Bentsen, M. et al. ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation. Nat. Commun. 11, 4267 (2020).","journal-title":"Nat. Commun."},{"key":"25872_CR31","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nmeth.4401","volume":"14","author":"AN Schep","year":"2017","unstructured":"Schep, A. N. et al. chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nat. Methods 14, 975\u2013978 (2017).","journal-title":"Nat. Methods"},{"key":"25872_CR32","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1172\/JCI46382","volume":"121","author":"D Chakravarty","year":"2011","unstructured":"Chakravarty, D. et al. Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation. J. Clin. Investig. 121, 4700\u20134711 (2011).","journal-title":"J. Clin. Investig."},{"key":"25872_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrendo.2014.186","volume":"11","author":"LP Fern\u00e1ndez","year":"2015","unstructured":"Fern\u00e1ndez, L. P., L\u00f3pez-M\u00e1rquez, A. & Santisteban, P. Thyroid transcription factors in development, differentiation and disease. Nat. Rev. Endocrinol. 11, 29\u201342 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"25872_CR34","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1073\/pnas.0900780106","volume":"106","author":"CA Pratilas","year":"2009","unstructured":"Pratilas, C. A. et al. V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway. Proc. Natl Acad. Sci. USA 106, 4519\u20134524 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25872_CR35","doi-asserted-by":"publisher","first-page":"7894","DOI":"10.1038\/sj.onc.1210588","volume":"26","author":"L Delys","year":"2007","unstructured":"Delys, L. et al. Gene expression and the biological phenotype of papillary thyroid carcinomas. Oncogene 26, 7894\u20137903 (2007).","journal-title":"Oncogene"},{"key":"25872_CR36","doi-asserted-by":"publisher","first-page":"F747","DOI":"10.1152\/ajprenal.00012.2014","volume":"307","author":"A Sanghi","year":"2014","unstructured":"Sanghi, A. et al. A knowledge base of vasopressin actions in the kidney. Am. J. Physiol. Ren. Physiol. 307, F747\u2013F755 (2014).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"25872_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/modpathol.3800235","volume":"18","author":"ML Prasad","year":"2005","unstructured":"Prasad, M. L. et al. Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod. Pathol. 18, 48\u201357 (2005).","journal-title":"Mod. Pathol."},{"key":"25872_CR38","doi-asserted-by":"publisher","first-page":"69903","DOI":"10.18632\/oncotarget.12065","volume":"7","author":"ES Linklater","year":"2016","unstructured":"Linklater, E. S. et al. Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers. Oncotarget 7, 69903\u201369915 (2016).","journal-title":"Oncotarget"},{"key":"25872_CR39","doi-asserted-by":"publisher","first-page":"D794","DOI":"10.1093\/nar\/gkx1081","volume":"46","author":"CA Davis","year":"2018","unstructured":"Davis, C. A. et al. The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 46, D794\u2013D801 (2018).","journal-title":"Nucleic Acids Res."},{"key":"25872_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00439-019-02044-2","volume":"139","author":"B Liu","year":"2020","unstructured":"Liu, B. & Montgomery, S. B. Identifying causal variants and genes using functional genomics in specialized cell types and contexts. Hum. Genet. 139, 95\u2013102 (2020).","journal-title":"Hum. Genet."},{"key":"25872_CR41","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41588-018-0046-7","volume":"50","author":"K Alasoo","year":"2018","unstructured":"Alasoo, K. et al. Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response. Nat. Genet. 50, 424\u2013431 (2018).","journal-title":"Nat. Genet."},{"key":"25872_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"25872_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471250953.bi1112s47","volume":"47","author":"AR Quinlan","year":"2014","unstructured":"Quinlan, A. R. BEDTools: the Swiss-Army Tool for genome feature analysis. Curr. Protoc. Bioinformatics 47, 1\u201334 (2014).","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"25872_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jmb.2004.02.048","volume":"338","author":"A Sandelin","year":"2004","unstructured":"Sandelin, A. & Wasserman, W. W. Constrained binding site diversity within families of transcription factors enhances pattern discovery bioinformatics. J. Mol. Biol. 338, 207\u2013215 (2004).","journal-title":"J. Mol. Biol."},{"key":"25872_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"25872_CR46","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"25872_CR47","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160\u2013W165 (2016).","journal-title":"Nucleic Acids Res."},{"key":"25872_CR48","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cell.2020.08.036","volume":"1","author":"L Jiang","year":"2020","unstructured":"Jiang, L. et al. A quantitative proteome map of the human body. Cell 1, 269\u2013283 (2020).","journal-title":"Cell"},{"key":"25872_CR49","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"25872_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins, P. et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55\u201362 (2016).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25872-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T15:29:43Z","timestamp":1669994983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25872-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25872"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25872-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"assertion":[{"value":"26 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.Y.C. is a co-founder of Accent Therapeutics and Boundless Bio and is an advisor to 10\u00d7 Genomics, Arsenal Biosciences, and Spring Discovery. M.P.S. is a co-founder and on the advisory board of Personalis, SensOmics, January, Filtricine, Qbio, Protos, Mirive, and Nimo. M.P.S. is also on the advisory board of Genapsys and Tailai. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5732"}}